Latest news
Larimar Therapeutics reports Q2 EPS (30c), consensus (38c) - TipRanksTipRanks · Tue, 04 Aug 2026 23:29:47 GMTLarimar reports Q2 results and nomlabofusp progress - TipRanksTipRanks · Tue, 04 Aug 2026 12:02:21 GMTLarimar Therapeutics 2Q 2026: Net loss $32.8M, Diluted EPS $(0.30) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 11:21:01 GMTLarimar Therapeutics (Nasdaq: LRMR) logs $62.4M loss and advances BLA - Stock TitanStock Titan · Tue, 04 Aug 2026 11:12:46 GMTLarimar Therapeutics Reports Second Quarter 2026 Financial and Business Update - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMTLarimar Therapeutics advances nomlabofusp with positive data, rolling FDA submission, and Phase 3 start in 2026 - PluangPluang · Tue, 04 Aug 2026 07:00:00 GMT